Skip to search formSkip to main contentSkip to account menu

Myelomonocytic leukemia

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
In the cure of cancer, a major cause of today's mortality, chemotherapy is the most common treatment, though serious frequent… 
Highly Cited
2015
Highly Cited
2015
Despite the recent identification of recurrent SETBP1 mutations in atypical chronic myeloid leukemia (aCML), a complete… 
Review
2015
Review
2015
In the last five years, IDH1 mutations in human malignancies have significantly shaped the diagnosis and management of cancer… 
Highly Cited
2012
Highly Cited
2012
Myeloproliferative neoplasms are frequently associated with aberrant constitutive tyrosine kinase (TK) activity resulting from… 
Highly Cited
2012
Highly Cited
2012
TET2 enzymatically converts 5-methyl-cytosine to 5-hydroxymethyl-cytosine, possibly leading to loss of DNA methylation. TET2… 
2006
2006
Abstract:  We analyzed the expression of the inhibitor of apoptosis survivin by immunocytochemistry in bone marrow cells from… 
Highly Cited
2004
Highly Cited
2004
Some regulators of plant growth and differentiation have been shown to induce the differentiation of several human myeloid… 
Highly Cited
2001
Highly Cited
2001
ABSTRACT Huntingtin-interacting protein 1 (HIP1) interacts with huntingtin, the protein whose gene is mutated in Huntington's… 
1987
1987
We report the case of a patient with scleromyxedema with abnormal monoclonal gamma globulin of the kappa type who was treated… 
1977
1977
Regulation of the growth and production of granulocyte colony-stimulating activity (CSA) by WEHI-3 cells, a lysozyme-secreting…